Marval O’Farrell Mairal advised Takeda on the transaction Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) has entered into an agreement to divest a selection of non-core products from the...
This content is for Standard 1 Year members only. LoginJoin Now